Speaker illustration

Professor A Michael Lincoff

Cleveland Clinic Foundation, Cleveland (United States of America)

Dr. Lincoff is Vice Chairman for Research of the Department of Cardiovascular Medicine and an interventional cardiologist at the Cleveland Clinic. He is the Director of the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), an academic research organization which plans and manages multicenter clinical trials. His research focuses on leadership of large scale trials testing therapies to reduce complications of coronary artery disease or reduce progression of atherosclerosis. He also supervises clinical research activities throughout the Cleveland Clinic as Director of the Center for Clinical Research of the Lerner Research Institute. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. Dr. Lincoff has authored or coauthored over 400 peer-reviewed articles and presented over 400 lectures throughout the world. He is a consultant for the United States FDA.

Patients benefit from omega-3 fatty acids: con – STRENGTH data.

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session: Great Debate: controversy – do patients benefit from omega-3 fatty acids?

Thumbnail

Prospects for clinical benefit with CETP inhibition in light of current and future trials.

Event: ESC CONGRESS 2016

Topic: Metabolism and metabolic syndromes

Session: Cardiovascular risk reduction and lipid management: state of the science

Thumbnail

Lipid Levels and CV Outcome with CETP Inhibition by Evacetrapib in the ACCELERATE Trial

Event: ESC CONGRESS 2016

Topic: Primary cardiovascular prevention: interventions and outcomes

Session: Clinical Trial Update Prevention

Thumbnail

This platform is supported by

logo Novo Nordisk